Literature DB >> 24943275

Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice.

Sungjune Kim1, Rupal Ramakrishnan, Sergio Lavilla-Alonso, Prakash Chinnaiyan, Nikhil Rao, Erin Fowler, John Heine, Dmitry I Gabrilovich.   

Abstract

There is a significant body of evidence demonstrating that radiation therapy (XRT) enhances the effect of immune therapy. However, the precise mechanisms by which XRT potentiates the immunotherapy of cancer remain elusive. Here, we report that XRT potentiates the effect of immune therapy via induction of autophagy and resultant trafficking of mannose-6-phopsphate receptor (MPR) to the cell surface. Irradiation of different tumor cells caused substantial up-regulation of MPR on the cell surface in vitro and in vivo. Down-regulation of MPR in tumor cells with shRNA completely abrogated the combined effect of XRT and immunotherapy (CTLA4 antibody) in B16F10-bearing mice without changes in the tumor-specific responses of T cells. Radiation-induced MPR up-regulation was the result of redistribution of the receptor to the cell surface. This effect was caused by autophagy with redirection of MPR to autophagosomes in a clathrin-dependent manner. In autophagosomes, MPR lost its natural ligands, which resulted in subsequent trafficking of empty receptor(s) back to the surface. Together, our data demonstrated a novel mechanism by which XRT can enhance the effect of immunotherapy and the molecular mechanism of this process.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24943275      PMCID: PMC4330093          DOI: 10.1007/s00262-014-1573-4

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  52 in total

1.  Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).

Authors:  Nina Aass; Pieter H M De Mulder; Gerald H J Mickisch; Peter Mulders; Allan T van Oosterom; Hein van Poppel; Sophie D Fossa; Linda de Prijck; Richard J Sylvester
Journal:  J Clin Oncol       Date:  2005-06-20       Impact factor: 44.544

Review 2.  Immunologically augmented cancer treatment using modern radiotherapy.

Authors:  Marco Durante; Norman Reppingen; Kathryn D Held
Journal:  Trends Mol Med       Date:  2013-07-04       Impact factor: 11.951

3.  Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice.

Authors:  Rupal Ramakrishnan; Deepak Assudani; Srinivas Nagaraj; Terri Hunter; Hyun-Il Cho; Scott Antonia; Soner Altiok; Esteban Celis; Dmitry I Gabrilovich
Journal:  J Clin Invest       Date:  2010-03-15       Impact factor: 14.808

Review 4.  TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions.

Authors:  C E Hill-Kayser; J P Plastaras; Z Tochner; E Glatstein
Journal:  Bone Marrow Transplant       Date:  2010-11-29       Impact factor: 5.483

5.  Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.

Authors:  Sandra Demaria; Noriko Kawashima; Anne Marie Yang; Mary Louise Devitt; James S Babb; James P Allison; Silvia C Formenti
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

6.  Endocytosed cation-independent mannose 6-phosphate receptor traffics via the endocytic recycling compartment en route to the trans-Golgi network and a subpopulation of late endosomes.

Authors:  Sharron X Lin; William G Mallet; Amy Y Huang; Frederick R Maxfield
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

Review 7.  Immunogenic cell death and DAMPs in cancer therapy.

Authors:  Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal:  Nat Rev Cancer       Date:  2012-11-15       Impact factor: 60.716

8.  Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

9.  Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer.

Authors:  Seagal Teitz-Tennenbaum; Qiao Li; Mary A Davis; Kari Wilder-Romans; Janet Hoff; Mu Li; Alfred E Chang
Journal:  J Immunother       Date:  2009 Jul-Aug       Impact factor: 4.456

10.  Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies.

Authors:  Inge Verbrugge; Jim Hagekyriakou; Leslie L Sharp; Mara Galli; Alison West; Nicole M McLaughlin; Hélène Duret; Hideo Yagita; Ricky W Johnstone; Mark J Smyth; Nicole M Haynes
Journal:  Cancer Res       Date:  2012-05-08       Impact factor: 12.701

View more
  23 in total

1.  Improved time to disease progression in the brain in patients with melanoma brain metastases treated with concurrent delivery of radiosurgery and ipilimumab.

Authors:  Tijana Skrepnik; Srinath Sundararajan; Haiyan Cui; Baldassarre Stea
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

2.  BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells.

Authors:  Cigdem Atay; Taekyoung Kwak; Sergio Lavilla-Alonso; Laxminarasimha Donthireddy; Allison Richards; Valerie Moberg; Shari Pilon-Thomas; Michael Schell; Jane L Messina; Vito W Rebecca; Min Xiao; Jiufeng Tan; Gao Zhang; Jeffrey S Weber; Meenhard Herlyn; Amod A Sarnaik; Dmitry I Gabrilovich
Journal:  Clin Cancer Res       Date:  2019-02-14       Impact factor: 12.531

Review 3.  The Future of Combining Carbon-Ion Radiotherapy with Immunotherapy: Evidence and Progress in Mouse Models.

Authors:  Takashi Shimokawa; Liqiu Ma; Ken Ando; Katsutoshi Sato; Takashi Imai
Journal:  Int J Part Ther       Date:  2016-08-29

Review 4.  Immune recognition of irradiated cancer cells.

Authors:  Erik Wennerberg; Claire Vanpouille-Box; Sophia Bornstein; Takahiro Yamazaki; Sandra Demaria; Lorenzo Galluzzi
Journal:  Immunol Rev       Date:  2017-11       Impact factor: 12.988

Review 5.  Emerging strategies to effectively target autophagy in cancer.

Authors:  V W Rebecca; R K Amaravadi
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

Review 6.  Combining Heavy-Ion Therapy with Immunotherapy: An Update on Recent Developments.

Authors:  Alexander Helm; Daniel K Ebner; Walter Tinganelli; Palma Simoniello; Alessandra Bisio; Valentina Marchesano; Marco Durante; Shigeru Yamada; Takashi Shimokawa
Journal:  Int J Part Ther       Date:  2018-09-21

Review 7.  The future of personalised radiotherapy for head and neck cancer.

Authors:  Jimmy J Caudell; Javier F Torres-Roca; Robert J Gillies; Heiko Enderling; Sungjune Kim; Anupam Rishi; Eduardo G Moros; Louis B Harrison
Journal:  Lancet Oncol       Date:  2017-04-26       Impact factor: 41.316

8.  Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.

Authors:  Weiyi Peng; Jie Qing Chen; Chengwen Liu; Shruti Malu; Caitlin Creasy; Michael T Tetzlaff; Chunyu Xu; Jodi A McKenzie; Chunlei Zhang; Xiaoxuan Liang; Leila J Williams; Wanleng Deng; Guo Chen; Rina Mbofung; Alexander J Lazar; Carlos A Torres-Cabala; Zachary A Cooper; Pei-Ling Chen; Trang N Tieu; Stefani Spranger; Xiaoxing Yu; Chantale Bernatchez; Marie-Andree Forget; Cara Haymaker; Rodabe Amaria; Jennifer L McQuade; Isabella C Glitza; Tina Cascone; Haiyan S Li; Lawrence N Kwong; Timothy P Heffernan; Jianhua Hu; Roland L Bassett; Marcus W Bosenberg; Scott E Woodman; Willem W Overwijk; Gregory Lizée; Jason Roszik; Thomas F Gajewski; Jennifer A Wargo; Jeffrey E Gershenwald; Laszlo Radvanyi; Michael A Davies; Patrick Hwu
Journal:  Cancer Discov       Date:  2015-12-08       Impact factor: 39.397

9.  Relationship between stromal regulatory T cells and the response to neoadjuvant chemotherapy for locally advanced rectal cancer.

Authors:  Kentaro Sekizawa; Kazuya Nakagawa; Yasushi Ichikawa; Hirokazu Suwa; Mayumi Ozawa; Masashi Momiyama; Atsushi Ishibe; Jun Watanabe; Mitsuyoshi Ota; Ikuma Kato; Itaru Endo
Journal:  Surg Today       Date:  2021-06-03       Impact factor: 2.549

10.  Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death.

Authors:  Dobrin Draganov; Sailesh Gopalakrishna-Pillai; Yun-Ru Chen; Neta Zuckerman; Sara Moeller; Carrie Wang; David Ann; Peter P Lee
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.